108 related articles for article (PubMed ID: 3105110)
21. Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT).
Himmelreich G; Dooijewaard G; Breinl P; Bechstein WO; Neuhaus P; Kluft C; Riess H
Thromb Haemost; 1993 Jan; 69(1):56-9. PubMed ID: 8446939
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
[TBL] [Abstract][Full Text] [Related]
23. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
[TBL] [Abstract][Full Text] [Related]
24. Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.
de Munk GA; Groeneveld E; Rijken DC
J Clin Invest; 1991 Nov; 88(5):1680-4. PubMed ID: 1658049
[TBL] [Abstract][Full Text] [Related]
25. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
Corti A; Nolli ML; Soffientini A; Cassani G
Thromb Haemost; 1986 Oct; 56(2):219-24. PubMed ID: 3101222
[TBL] [Abstract][Full Text] [Related]
26. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.
Declerck PJ; Verstreken M; Collen D
Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114
[TBL] [Abstract][Full Text] [Related]
27. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
Ugwu F; Lemmens G; Collen D; Lijnen HR
Thromb Haemost; 1999 Sep; 82(3):1127-31. PubMed ID: 10494776
[TBL] [Abstract][Full Text] [Related]
28. Construction and Characterization of a Mutant of Single-chain Urokinase-type Plasminogen Activator Ser(175)-His(187)-mscu-PA.
Xue YM; Zhu H; Shi W; Liu W; Liu JN; Ma Z
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2000; 32(1):26-30. PubMed ID: 12110908
[TBL] [Abstract][Full Text] [Related]
29. Half-life of single-chain urokinase-type plasminogen activator (scu-PA) and two-chain urokinase-type plasminogen activator (tcu-PA) in patients with acute myocardial infarction.
Köhler M; Sen S; Miyashita C; Hermes R; Pindur G; Heiden M; Berg G; Mörsdorf S; Leipnitz G; Zeppezauer M
Thromb Res; 1991 Apr; 62(1-2):75-81. PubMed ID: 1906642
[TBL] [Abstract][Full Text] [Related]
30. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
Lind SE; Smith CJ
Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
Collen D; Stassen JM; De Cock F
Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
[TBL] [Abstract][Full Text] [Related]
32. [Assay and detection methods for urokinase-type plasminogen activator and its related-factors].
Kimura K; Endo Y; Sasaki T
Gan To Kagaku Ryoho; 1999 Jun; 26(7):1009-17. PubMed ID: 10396332
[TBL] [Abstract][Full Text] [Related]
33. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator.
Lijnen HR; Van Hoef B; Collen D
Biochim Biophys Acta; 1986 Dec; 884(3):402-8. PubMed ID: 3778931
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of single chain forms of urokinase-type plasminogen activator.
Stump DC; Kieckens L; De Cock F; Collen D
J Pharmacol Exp Ther; 1987 Jul; 242(1):245-50. PubMed ID: 3612530
[TBL] [Abstract][Full Text] [Related]
35. Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator.
van Griensven JM; Huisman LG; Stuurman T; Dooijewaard G; Kroon R; Schoemaker RC; Kluft K; Cohen AF
Clin Pharmacol Ther; 1996 Nov; 60(5):504-11. PubMed ID: 8941023
[TBL] [Abstract][Full Text] [Related]
36. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
Berkenpas MB; Quigley JP
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7768-72. PubMed ID: 1652763
[TBL] [Abstract][Full Text] [Related]
37. The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.
Braat EA; Collen A; Jie AF; Grimbergen JM; Rijken DC
Biochim Biophys Acta; 2000 Sep; 1497(3):351-8. PubMed ID: 10996659
[TBL] [Abstract][Full Text] [Related]
38. High-level scu-PA production by butyrate-treated serum-free culture of recombinant CHO cell line.
Kim JS; Ahn BC; Lim BP; Choi YD; Jo EC
Biotechnol Prog; 2004; 20(6):1788-96. PubMed ID: 15575713
[TBL] [Abstract][Full Text] [Related]
39. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
Wolf BB; Vasudevan J; Henkin J; Gonias SL
J Biol Chem; 1993 Aug; 268(22):16327-31. PubMed ID: 8393859
[TBL] [Abstract][Full Text] [Related]
40. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single chain- urokinase.
Stief TW; Stief MH; Ehrenthal W; Darius H; Martin E
Thromb Res; 1991 Dec; 64(5):597-610. PubMed ID: 1808764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
